Author:
Sautner J.,Eichbauer-Sturm G.,Gruber J.,Lunzer R.,Puchner R.
Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. Xia Y, Wu Q, Wang H et al (2020) Global, regional and national burden of gout, 1990–2017: a systematic analysis of the global burden of disease study. Baillieres Clin Rheumatol 59:1529–1538
2. Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricemia in the US general population: the national health and nutrition examination survey 2007–2008. Arthritis Rheum 63:3136–3141
3. Choi HK, McCormick N, Yokose C (2022) Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care. Nat Rev Rheumatol 18(2):97–111. https://doi.org/10.1038/s41584-021-00725-9
4. Richette P, Doherty M, Pascual E et al (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76:29–42
5. Kiltz U, Smolen J, Bardin J et al (2017) Treat-to-target (T2T) recommendations for gout. Ann Rheum Dis 76:632–638